This opportunity is no longer accepting applications.
grant PAR-24-203

Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)

This grant opportunity invites R01 applications for studies using animal, cell culture, or human tissue models to explore how COVID-19 impacts Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD). Proposals should include models or experimental outcomes that incorporate AD/ADRD risk factors, pathologies, or comorbidities. Research can focus on: 1) how COVID-19 affects cent…

This NOFO will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to inc…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $500,000
Award Amount: $500,000

Dates

Submission Deadline: October 4, 2024
Application Window Closes: October 4, 2024
Opportunity Released: April 12, 2024
Open for Submission: April 12, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.